Skip to main content
Toggle navigation
Login
Search
Home
Tweets by 2023 SSO Annual Meeting
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Home
Browse by Speaker
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
D
Da Forno, Philip
University Hospitals of Leicester NHS Trust, Leicester, UK
62: Validation of Invasive Area for Predicting Sentinel Node Status and Survival in Melanoma
Location:Veterans Memorial Auditorium
Philip Da Forno
D’Angelica, Michael
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Michael D’Angelica
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Michael D’Angelica
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Michael D’Angelica
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Michael D’Angelica
Dang, Catherine
Cedars-Sinai Medical Center
15: A Prospective Study of Sentinel Node Biopsy Omission in Women Age ≥ 65 with Early Invasive ER+ Breast Cancer Undergoing Breast Conserving Surgery
Location:Veterans Memorial Auditorium
Catherine Dang
D'Angelo, Sandra
Department of Medicine
74: Interim Results of a Phase II Trial of Regional Melphalan via Limb Infusion and Systemic PD1 Blockade in Patients with Extremity Sarcoma
Location:Veterans Memorial Auditorium
Sandra D'Angelo
Daniel, Sara
Stanford University School of Medicine
78: Detection of Circulating Tumor DNA Predicts Recurrence in Soft Tissue Sarcomas
Location:Ballroom A
Sara Daniel
Danos, Denise
LSU HSC New Orleans
30: Cytoreduction in Patients with Metastatic Pancreatic Neuroendocrine Tumors and the Clinical Factors Driving Outcomes
Location:Ballroom A
Denise Danos
Danziger, Natalie
Foundation Medicine Inc
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Natalie Danziger
Darrow, Morgan
Department of Pathology and Laboratory Medicine, UC Davis
P37: Characterization of Natural Killer and Cytotoxic T Cell Immune Infiltrates in Pancreatic Ductal Adenocarcinoma
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Morgan Darrow
Datta, Jashodeep
University of Miami
37: Hepatic Artery Infusion Chemotherapy Compared to Y90 for Treatment of Unresectable Colorectal Liver Metastases: A Multi-Institutional Comparative Study
Location:Ballroom B
Jashodeep Datta
43: Optimal Duration of Chemotherapy in the Era of Neoadjuvant Therapy for Pancreatic Adenocarcinoma - Is There a Magic Number?
Location:Ballroom B
Jashodeep Datta
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Jashodeep Datta
Dave, Yatee
University of Rochester Medical Center
44: Pten deletion-induced murine model of cholangiocarcinoma: a pathologic and immune analysis
Location:Ballroom B
Yatee Dave
46: Pan-Lysyl Oxidase Inhibition Disrupts Macrophage Invasion and Renders Tumor-Associated Macrophages Susceptible to Cytotoxic Chemotherapy in Cholangiocarcinoma
Location:Ballroom A
Yatee Dave
P45: Dietary fish oil impairs melanoma growth and augments the tumor immune microenvironment in anti-PD-1 treated melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Yatee Dave
David, Elizabeth
University of Colorado School of Medicine, Department of Surgery, Division of Cardiothoracic Surgery
P77: Prospective Evaluation of a Universally Applied Laparoscopic Gastric Ischemic Preconditioning Protocol Prior to Esophagectomy with Comparison to Historical Controls
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Elizabeth David
Davis, Jeremy
National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Jeremy Davis
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jeremy Davis
P74: Perceptions of Readiness for Practice after Complex General Surgical Oncology Fellowship: A Survey Study
Location:SSO HUB: Rare/Metastatic Cancers Zone
Jeremy Davis
Day, Courtney
Mayo Clinic Rochester
P4: Clinical Behavior, Management and Treatment Response of Estrogen Receptor Low (1-10%) Breast Cancer by PR expression
Location:SSO HUB: Breast & Endocrine Zone
Courtney Day
Dayyani, Farshid
University of California, Irvine
P49: Convolutional Neural Network to Predict Peritoneal Carcinomatosis Risk in Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Farshid Dayyani
De Castro Silva, Iago
University of Miami School of Medicine - Miami, Fl
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Iago De Castro Silva
de la Cruz Merino, Luis
Hospital Universitario Virgen Macarena, Seville, Spain
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Luis de la Cruz Merino
Dedeilia, Aikaterini
Massachusetts General Hospital
P48: Increased Frequency of Gene Mutations Significantly Decreases Recurrence Risk In High-Risk Stage II Melanoma Patients.
Location:SSO HUB: Melanoma & Sarcoma Zone
Aikaterini Dedeilia
Del Chiaro, Marco
University of Colorado School of Medicine, Department of Surgery, Division of Surgical Oncology
P19: Pathological Features Associated With Lymph Node Disease in Patients with Appendiceal Neuroendocrine Tumors.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Marco Del Chiaro
P38: Dynamic anthropometrics: sarcopenia and survival in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Marco Del Chiaro
Del Vecchio, Michele
Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
54: Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Tumor Location in the Phase 3 KEYNOTE-716 Study
Location:Veterans Memorial Auditorium
Michele Del Vecchio
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Michele Del Vecchio
Delitto, Andrea
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Andrea Delitto
Delitto, Daniel
Stanford University
39: Mechanoresponsive Pancreatic Ductal Adenocarcinoma Cancer Associated Fibroblasts Shows an FAK-Dependent Subtype Divergent from Canonical Fibrotic TGFB-Pathway Dependence
Location:Ballroom B
Daniel Delitto
Dellinger, Thanh
City of Hope National Medical Center
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Thanh Dellinger
Delman, Keith
Emory University
55: Neoadjuvant Pepinemab in Combination with Nivolumab and/or Ipilimumab in Resectable Stage III Melanoma
Location:Veterans Memorial Auditorium
Keith Delman
Melanoma in Pregnancy
Location:SSO HUB Theater
Keith Delman
DeLozier, Olivia
The University of Tennessee Health Science Center
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Olivia DeLozier
DeMatteo, Ronald
The Hospital of the University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Ronald DeMatteo
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)
Location:Ballroom A
Ronald DeMatteo
Surgical Cytoreduction for Metastatic GIST: Who, When, and Why?
Location:SSO HUB: Melanoma & Sarcoma Zone
Ronald DeMatteo
Demetri, George
Dana-Farber Cancer Institute and Harvard Medical School
Surgical Cytoreduction for Metastatic GIST: Who, When, and Why?
Location:SSO HUB: Melanoma & Sarcoma Zone
George Demetri
Denesh, Keren
Tel Aviv Sourasky Medical Center
P81: Neoadjuvant Chemotherapy for Gastric Cancer in the Elderly: Are We Accomplishing Our Treatment Goals or Should we Consider an Upfront Surgery Approach
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Keren Denesh
Deneve, Jeremiah
University of Tennessee Health Science Center
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Jeremiah Deneve
Deng, Xiaoyan
Virginia Commonwealth University Department of Biostatistics
13: Luminal A vs B After Choosing Wisely: Do Phenotypes Affect Oncologic Outcomes?
Location:Veterans Memorial Auditorium
Xiaoyan Deng
DePalo, Danielle
Moffitt Cancer Center
58: Timing of Adjuvant Immunotherapy in Stage III Melanoma, Does it Matter?
Location:Veterans Memorial Auditorium
Danielle DePalo
P41: A Multi-Institution Observational Analysis of the Theory of the Immunization Effect in Patients with Multiple Primary Melanomas
Location:SSO HUB: Melanoma & Sarcoma Zone
Danielle DePalo
DePeralta, Danielle
Zucker School of Medicine at Hofstra/Northwell Health
P54: A comparative evaluation of efficacy endpoints in colorectal and appendiceal carcinomatosis treated with PIPAC: Secondary analysis of a US multicenter phase 1 trial
Location:SSO HUB: Rare/Metastatic Cancers Zone
Danielle DePeralta
Derby, Joshua
University of Pittsburgh Medical Center
73: Predicting Early Recurrence to optimize Patient Selection for Cytoreductive Surgery-Hyperthermic Intraperitoneal Chemotherapy in High-Grade Appendiceal Mucinous Carcinoma Peritonei
Location:Ballroom B
Joshua Derby
P52: Impact of Primary Tumor Location and Genomic Alterations on Survival Following Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion for Colorectal Peritoneal Metastases
Location:SSO HUB: Rare/Metastatic Cancers Zone
Joshua Derby
Desai, Anant
University Hospital Birmingham NHS Foundation Trust
P62: Risk Factors for the Development of Early Recurrence in Patients with Primary Retroperitoneal Sarcoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Anant Desai
Deshpande, Anagha
Mayo Clinic Alix School of Medicine, Scottsdale, Arizona
P63: Is there a benefit to radiation and surgery in specific histologic subtypes of retroperitoneal sarcoma?
Location:SSO HUB: Melanoma & Sarcoma Zone
Anagha Deshpande
Dhiman, Ankit
Department of Surgery, Medical College of Georgia, Augusta University, Augusta, GA
P53: Therapeutic Implications of Germline Testing in Peritoneal Mesothelioma
Location:SSO HUB: Rare/Metastatic Cancers Zone
Ankit Dhiman
Di Lena, Elise
McGill University
P12: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast Conserving Surgery After Neoadjuvant Chemotherapy
Location:SSO HUB: Breast & Endocrine Zone
Elise Di Lena
Diaz, Adrian
The Ohio State University
86: Identifying Characteristics of High-Performing Hospital Networks for Major Cancer Surgery
Location:Ballroom B
Adrian Diaz
89: Variation in Postoperative Outcomes Across CMS Hospital Star Ratings for complex Cancer Surgery
Location:Ballroom B
Adrian Diaz
P72: Association Of Hospital Network Affiliation with Surgical Outcomes and Spending For Complex Cancer: A longitudinal study of hospital mergers and acquisitions from 2010 to 2018
Location:SSO HUB: Rare/Metastatic Cancers Zone
Adrian Diaz
DiBrito, Sandra
Albany Medical College
SSO Top-Rated Video Abstracts
Location:Veterans Memorial Auditorium
Sandra DiBrito
Dickson, Paxton
University of Tennessee Health Science Center
Management of Advanced Thyroid Cancer in the Era of Targeted Therapy
Location:SSO HUB Theater
Paxton Dickson
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Paxton Dickson
Diego, Emilia
University of Pittsburgh
11: Genomic Landscape of Malignant Phyllodes Tumors Reveals Multiple Targetable Opportunities
Location:Veterans Memorial Auditorium
Emilia Diego
7: Multicenter clinical trial for omission of breast surgery in invasive cancer following neoadjuvant systemic therapy: Longitudinal patient reported outcomes and decisional comfort planned analyses
Location:Veterans Memorial Auditorium
Emilia Diego
Diehn, Maximilian
Stanford University
Questions and Discussion
Location:Ballroom A
Maximilian Diehn
The Use of ctDNA in the management of thoracic malignancies: Current use and future directions
Location:Ballroom A
Maximilian Diehn
Difilippantonio, Simone
Laboratory Animal Sciences Program, National Cancer Institute
40: Pre-clinical and clinical evaluation of tivozanib for Exportin 7/Ste20-like-kinase (XPO7/SLK)-expressing cholangiocarcinoma
Location:Ballroom B
Simone Difilippantonio
Dimick, Justin
University of Michigan
89: Variation in Postoperative Outcomes Across CMS Hospital Star Ratings for complex Cancer Surgery
Location:Ballroom B
Justin Dimick
P72: Association Of Hospital Network Affiliation with Surgical Outcomes and Spending For Complex Cancer: A longitudinal study of hospital mergers and acquisitions from 2010 to 2018
Location:SSO HUB: Rare/Metastatic Cancers Zone
Justin Dimick
Ding, Qian
Quantum Leap Healthcare Collaborative
3: Changes in axillary surgical management over 10 years – report on > 1400 breast cancer patients treated with neoadjuvant chemotherapy on I-SPY2
Location:Veterans Memorial Auditorium
Qian Ding
DiPeri, Timothy
The University of Texas MD Anderson Cancer Center
32: Impact of Primary Tumor Resection on Metastatic Well-Differentiated Gastroenteropancreatic Neuroendocrine Tumors
Location:Ballroom A
Timothy DiPeri
Diskin, Brian
Memorial Sloan Kettering Cancer Center
P3: Diagnosing lymphedema after axillary surgery: which method is superior?
Location:SSO HUB: Breast & Endocrine Zone
Brian Diskin
Dizon, Don
Legorreta Cancer Center of Brown University
P7: Genomic characterization of breast cancer metastases reveals differences in rates of PIK3CA mutation across metastatic sites and worse survival in patients with concurrent CDH1 mutation treated with PI3K inhibitor
Location:SSO HUB: Breast & Endocrine Zone
Don Dizon
Do, Kevin
University of Pennsylvania
75: T cell Inducible Costimulator (ICOS) blockade increases the efficacy of imatinib in Gastrointestinal Stromal Tumor (GIST)
Location:Ballroom A
Kevin Do
91: CD40 activation has direct tumor effects in gastrointestinal stromal tumor (GIST)
Location:Ballroom A
Kevin Do
Do, Kun
NIBIB/IRP
P51: Hyperthermic intraperitoneal chemotherapy restores physiologic tumor stiffness & stimulates lymphocyte proliferation & recruitment
Location:SSO HUB: Rare/Metastatic Cancers Zone
Kun Do
Dominici, Laura
Dana-Farber/Brigham Cancer Center
PeerView Independent Satellite Symposium: Navigating Complex Decisions at the Intersection of Local and Systemic Management of Early Breast Cancer
Location:Room 304
Laura Dominici
Dong, Weichuan
Case Western Reserve University School of Medicine, Cleveland, Ohio
98: Disparities in Receipt of Complex GI Cancer Surgery at a Small Geographic Scale
Location:Ballroom A
Weichuan Dong
P69: Understanding Factors Leading to Surgical Attrition for “Resectable” Gastric Cancer
Location:SSO HUB: Rare/Metastatic Cancers Zone
Weichuan Dong
Donnenberg, Albert
University of Pittsburgh Medical Center
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Albert Donnenberg
Donnenberg, Vera
University of Pittsburgh Medical Center
69: Peritoneal fluid cytokine analysis reveals targets for regional immunotherapy in carcinomatosis
Location:Ballroom B
Vera Donnenberg
Dosch, Austin
University of Miami, Miller School of Medicine, Department of Surgery
P32: p38 MAPK inhibition reprograms the inflammatory stroma to overcome the immunosuppressive tumor microenvironment in pancreatic cancer
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Austin Dosch
Dossett, Lesly
University of Michigan
De-escalation of Surgery for Melanoma
Location:Ballroom C
Lesly Dossett
Omission of Sentinel Node in Patients > 70
Location:Ballroom B
Lesly Dossett
Questions and Discussion
Location:Ballroom B
Lesly Dossett
Drake, Justin
Moffitt Cancer Center
97: Long-term Oncologic Outcomes Following Pathologic Complete Response (pCR) for Esophageal Cancer
Location:Ballroom A
Justin Drake
P27: Follicular Thyroid Carcinoma with Nodal Metastases: A National Study
Location:SSO HUB: Breast & Endocrine Zone
Justin Drake
Drapalik, Lauren
University Hospitals / Case Western University School of Medicine
P26: Applying 8th edition AJCC guidelines to differentiated thyroid cancer: Stage migration and impact on overall survival
Location:SSO HUB: Breast & Endocrine Zone
Lauren Drapalik
Dream, Sophie
Medical College of Wisconsin
P22: Adoption of Robotic Adrenalectomy is Associated with a Short Learning Curve and Improved Outcomes
Location:SSO HUB: Breast & Endocrine Zone
Sophie Dream
Drebin, Harrison
Memorial Sloan Kettering Cancer Center
93: Effectiveness of Sentinel Lymph Node Mapping in Gastric Cancer
Location:Ballroom A
Harrison Drebin
P42: Clinical Benefit of Sentinel Lymph Node Biopsy Nomograms for Head and Neck Melanoma
Location:SSO HUB: Melanoma & Sarcoma Zone
Harrison Drebin
P82: Short- and Long- Term Outcomes of Minimally Invasive vs Open Gastrectomy after Neoadjuvant Chemotherapy for Gastric cancer.
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Harrison Drebin
Drebin, Jeffrey
Hepatopancreatobiliary Service, Department of Surgery, Memorial Sloan Kettering Cancer Center
27: The Prognostic Value of Pre- and Post-Neoadjuvant Chemotherapy Serum Carcinoembryonic Antigen Levels in Patients Having Resection of Colorectal Liver Metastases
Location:Ballroom C
Jeffrey Drebin
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Jeffrey Drebin
52: Adjuvant chemotherapy for resected intrahepatic cholangiocarcinoma confers no survival advantage.
Location:Ballroom A
Jeffrey Drebin
Driedger, Michael
Atrium Health Carolinas Medical Center
47: Surgical Microwave Ablation for Treatment of Hepatocellular Carcinoma: A Single Institution Review from 2006-2022
Location:Ballroom A
Michael Driedger
Drill, Esther
Memorial Sloan Kettering Cancer Center
35: Genetic Heterogeneity of Intrahepatic Cholangiocarcinoma: Implications for Outcome
Location:Veterans Memorial Auditorium
Esther Drill
Dry, Sarah
UCLA Health
79: Dysregulation of Mitochondrial Dynamics via Dynamin-Related Protein 1 Implicated in Dedifferentiated Liposarcoma
Location:Ballroom A
Sarah Dry
Dudeja, Vikas
University of Alabama
Basics of Funding Agencies
Location:Room 304
Vikas Dudeja
Dudgeon, Crissy
Rutgers University
50: Anti-Netrin-1 Therapy Inhibits Metastasis and Improves Survival in Pancreatic Cancer
Location:Ballroom A
Crissy Dudgeon
Dunki-Jacobs, Erik
TriHealth Cancer Institute
"Help the Doctor": How Best to Utilize APCs in Your Surgical Oncology Practice
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Erik Dunki-Jacobs
Dunlop, Hayley
The Ohio State University College of Medicine
82: Socioeconomic Disparities in the Treatment and Survival of Extremity Soft Tissue Sarcoma
Location:Ballroom B
Hayley Dunlop
Dunne, Richard
University of Rochester Medical Center
P34: Determining Safety and Tolerability of SX-682 in Combination with Anti-PD1 as Maintenance Therapy for Unresectable Pancreatic Adenocarcinoma, A Phase I Study
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Richard Dunne
Dunworth, Matthew
Department of Cell Biology, School of Medicine, Johns Hopkins University
71: Intra-and interpatient drug response heterogeneity exist in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for gastrointestinal cancers
Location:Ballroom B
Matthew Dunworth
Durani, Piyush
Bristol Myers Squibb
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Piyush Durani
Durham, Demetrius
Garnet Health Medical Center
P80: Accuracy of Clinical Staging for Intramural (T2) Gastric Cancer: Survival Outcomes Following Upfront Surgical Resection Compared to Risk of Overtreatment with Neoadjuvant Therapy
Location:SSO HUB Pan-Tumor Zone: CRS, HPB, Pan-Tumor & Upper GI
Demetrius Durham
Dutriaux, Caroline
Hôpital Saint André
63: Adjuvant therapy with nivolumab versus placebo in patients with resected stage IIB/C melanoma (CheckMate 76K)
Location:Veterans Memorial Auditorium
Caroline Dutriaux
Dy, Benzon
Mayo Clinic
P28: Hurthle cell carcinoma - Is a hemithyroidectomy enough?
Location:SSO HUB: Breast & Endocrine Zone
Benzon Dy
Dye, Charles
Penn State Health
103: Endoscopic-assisted Laparoscopic Transgastric Partial Gastrectomy for Gastroesophageal Junction Gastrointestinal Stromal Tumor
Location:Veterans Memorial Auditorium
Charles Dye
Dy, Grace
Roswell Park Comprehensive Cancer Center
94: Single-cell profiling of tumor-infiltrating T-cell clones in longitudinal peripheral blood samples for clinical studies
Location:Ballroom A
Grace Dy
Back to Top
